Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Chinese investigators describe antimycoplasmal activity of new quinolone

Dec. 23, 1999

FDA is first agency worldwide to approve new fluoroquinolone for marketing

Dec. 22, 1999

Neose Technologies discontinues development of NE-1530

Dec. 21, 1999

Banyu isolates novel antifungal substance BE-54753

Dec. 21, 1999

FDA approves topical treatment for nail fungus

Dec. 21, 1999

German launch announced for flu drug

Dec. 20, 1999

WHO takes over to ensure continued availability of antitrypanosomal agent

Dec. 20, 1999

Antiviral compounds useful against picornaviruses and hepatitis viruses synthesized at Lilly

Dec. 17, 1999

Relenza now available in Canada for treament of influenza

Dec. 17, 1999

SmithKline Beecham seeks approval of Factive in U.S.

Dec. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.